| Product NDC: | 25021-813 |
| Proprietary Name: | Leucovorin |
| Non Proprietary Name: | leucovorin calcium |
| Active Ingredient(s): | 50 mg/5mL & nbsp; leucovorin calcium |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 25021-813 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA200753 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120915 |
| Package NDC: | 25021-813-10 |
| Package Description: | 10 VIAL in 1 CARTON (25021-813-10) > 5 mL in 1 VIAL |
| NDC Code | 25021-813-10 |
| Proprietary Name | Leucovorin |
| Package Description | 10 VIAL in 1 CARTON (25021-813-10) > 5 mL in 1 VIAL |
| Product NDC | 25021-813 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | leucovorin calcium |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20120915 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | LEUCOVORIN CALCIUM |
| Strength Number | 50 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Folate Analog [EPC],Folic Acid [Chemical/Ingredient] |